Overview

Evaluation of the Long-term Safety and Effectiveness of Suzetrigine (SUZ) in Participants With Painful Diabetic Peripheral Neuropathy (DPN)

Status:
ENROLLING_BY_INVITATION
Trial end date:
2027-01-25
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the long-term safety and tolerability of SUZ and long-term effectiveness of SUZ in treating pain associated with DPN.
Phase:
PHASE3
Details
Lead Sponsor:
Vertex Pharmaceuticals Incorporated